Geriatric Medicines - Global Market Outlook (2017-2026)

Geriatric Medicines - Global Market Outlook (2017-2026)

  • Published: April 2018
  • ID: SMRC17212

According to Stratistics MRC, the Global Geriatric Medicines Market is expected to grow at a CAGR of 9.3% during the forecast period. Increasing occurrence of diabetes and cardiovascular diseases amongst old people, increase in government support, improving healthcare infrastructure in number of upcoming economies are some of the key factors favouring the market growth. However, factors such as lack of awareness need of patient participation in clinical trials and side effects of medicines are hindering the market growth. In addition, increasing demand from emerging economies holds huge growth opportunities for market growth.

Geriatrics is a division of medicines connected to the remedial, clinical, social, and preventive aspects of ill health among old people over 65 years. The majority of the geriatrics is not capable to take their medication correctly at the intended time due to difficult in psychological and medical issues. The geriatric inhabitants need special attention and care for the rapid recovery of disorder or disease.

By Therapeutic Category, antihypertensive segment is projected to have significant share during the forecast period. Antihypertensive are a group of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy prevents problems of high blood pressure such as stroke and myocardial infarction. Restless lifestyle of the urban populations and growing life expectancy are favouring the growth of antihypertensive medicines for geriatrics. By Geography, North America region is projected to grow at a significant rate due to high prevalence of chronic diseases, favourable administration initiative for the old people and presence of some pioneering companies of this market.

Some of the key players in geriatrics medicine market includes Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc., Merck & Company Inc, Novartis AG, Pfizer and Inc., Sanofi S.A.

Therapeutic Categories Covered:
• Analgesic
• Antidiabetic
• Antihypertensive
• Antidepressant & Antipsychotic
• Proton Pump Inhibitor (PPI)
• Statins
• Other Therapeutic Categories

Conditions Covered:                                            
• Arthritis 
• Cancer 
• Cardiovascular 
• Neurological 
• Osteoporosis 
• Respiratory 
• Other Conditions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

 

1 Executive Summary     
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.7 Emerging Markets    
 3.8 Futuristic Market Scenario   
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Geriatric Medicines Market, By Therapeutic Category 
 5.1 Introduction     
 5.2 Analgesic     
 5.3 Antidiabetic     
 5.4 Antihypertensive     
 5.5 Antidepressant & Antipsychotic  
 5.6 Proton Pump Inhibitor (PPI)    
 5.7 Statins      
 5.8 Other Therapeutic Categories    
       
6 Global Geriatric Medicines Market, By Condition  
 6.1 Introduction    
 6.2 Arthritis      
 6.3 Cancer      
 6.4 Cardiovascular     
 6.5 Neurological     
 6.6 Osteoporosis     
 6.7 Respiratory     
 6.8 Other Conditions     
       
7 Global Geriatric Medicines Market, By Geography
  
 7.1 Introduction    
 7.2 North America    
  7.2.1 US    
  7.2.2 Canada    
  7.2.3 Mexico    
 7.3 Europe     
  7.3.1 Germany    
  7.3.2 UK    
  7.3.3 Italy    
  7.3.4 France    
  7.3.5 Spain    
  7.3.6 Rest of Europe   
 7.4 Asia Pacific    
  7.4.1 Japan    
  7.4.2 China    
  7.4.3 India    
  7.4.4 Australia    
  7.4.5 New Zealand   
  7.4.6 South Korea   
  7.4.7 Rest of Asia Pacific   
 7.5 South America    
  7.5.1 Argentina   
  7.5.2 Brazil    
  7.5.3 Chile    
  7.5.4 Rest of South America  
 7.6 Middle East & Africa   
  7.6.1 Saudi Arabia   
  7.6.2 UAE    
  7.6.3 Qatar    
  7.6.4 South Africa   
  7.6.5 Rest of Middle East & Africa  
       
8 Key Developments     
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
 8.2 Acquisitions & Mergers   
 8.3 New Product Launch   
 8.4 Expansions    
 8.5 Other Key Strategies   
       
9 Company Profiling     
 9.1 Abbott Laboratories, Inc.   
 9.2 AstraZeneca plc    
 9.3 Boehringer Ingelheim GmbH   
 9.4 Bristol-Myers Squibb Company  
 9.5 Eli Lilly and Company   
 9.6 GlaxoSmithKline Plc.   
 9.7 Merck & Company Inc   
 9.8  Novartis AG    
 9.9 Pfizer, Inc.    
 9.10 Sanofi S.A    

 


List of Tables      
1 Global Geriatric Medicines Market Outlook, By Region (2016-2026) (US $MN)
2 Global Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
3 Global Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
4 Global Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
5 Global Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
6 Global Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
7 Global Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
8 Global Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
9 Global Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
10 Global Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
11 Global Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
12 Global Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
13 Global Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
14 Global Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
15 Global Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
16 Global Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
17 Global Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)
18 North America Geriatric Medicines Market Outlook, By Country (2016-2026) (US $MN)
19 North America Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
20 North America Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
21 North America Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
22 North America Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
23 North America Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
24 North America Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
25 North America Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
26 North America Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
27 North America Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
28 North America Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
29 North America Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
30 North America Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
31 North America Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
32 North America Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
33 North America Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
34 North America Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)
35 Europe Geriatric Medicines Market Outlook, By Country (2016-2026) (US $MN)
36 Europe Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
37 Europe Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
38 Europe Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
39 Europe Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
40 Europe Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
41 Europe Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
42 Europe Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
43 Europe Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
44 Europe Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
45 Europe Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
46 Europe Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
47 Europe Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
48 Europe Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
49 Europe Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
50 Europe Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
51 Europe Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)
52 Asia Pacific Geriatric Medicines Market Outlook, By Country (2016-2026) (US $MN)
53 Asia Pacific Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
54 Asia Pacific Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
55 Asia Pacific Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
56 Asia Pacific Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
57 Asia Pacific Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
58 Asia Pacific Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
59 Asia Pacific Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
60 Asia Pacific Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
61 Asia Pacific Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
62 Asia Pacific Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
63 Asia Pacific Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
64 Asia Pacific Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
65 Asia Pacific Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
66 Asia Pacific Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
67 Asia Pacific Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
68 Asia Pacific Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)
69 South America Geriatric Medicines Market Outlook, By Country (2016-2026) (US $MN)
70 South America Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
71 South America Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
72 South America Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
73 South America Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
74 South America Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
75 South America Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
76 South America Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
77 South America Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
78 South America Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
79 South America Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
80 South America Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
81 South America Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
82 South America Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
83 South America Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
84 South America Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
85 South America Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)
86 Middle East & Africa Geriatric Medicines Market Outlook, By Country (2016-2026) (US $MN)
87 Middle East & Africa Geriatric Medicines Market Outlook, By Therapeutic Category (2016-2026) (US $MN)
88 Middle East & Africa Geriatric Medicines Market Outlook, By Analgesic  (2016-2026) (US $MN)
89 Middle East & Africa Geriatric Medicines Market Outlook, By Antidiabetic (2016-2026) (US $MN)
90 Middle East & Africa Geriatric Medicines Market Outlook, By Antihypertensive (2016-2026) (US $MN)
91 Middle East & Africa Geriatric Medicines Market Outlook, By Antidepressant & Antipsychotic (2016-2026) (US $MN)
92 Middle East & Africa Geriatric Medicines Market Outlook, By Proton Pump Inhibitor (PPI)  (2016-2026) (US $MN)
93 Middle East & Africa Geriatric Medicines Market Outlook, By Statins (2016-2026) (US $MN)
94 Middle East & Africa Geriatric Medicines Market Outlook, By Other Therapeutic Categories (2016-2026) (US $MN)
95 Middle East & Africa Geriatric Medicines Market Outlook, By Condition (2016-2026) (US $MN)
96 Middle East & Africa Geriatric Medicines Market Outlook, By Arthritis (2016-2026) (US $MN)
97 Middle East & Africa Geriatric Medicines Market Outlook, By Cancer (2016-2026) (US $MN)
98 Middle East & Africa Geriatric Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
99 Middle East & Africa Geriatric Medicines Market Outlook, By Neurological (2016-2026) (US $MN)
100 Middle East & Africa Geriatric Medicines Market Outlook, By Osteoporosis (2016-2026) (US $MN)
101 Middle East & Africa Geriatric Medicines Market Outlook, By Respiratory (2016-2026) (US $MN)
102 Middle East & Africa Geriatric Medicines Market Outlook, By Other Conditions  (2016-2026) (US $MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials